TY - JOUR
T1 - The Chicago Consensus on peritoneal surface malignancies
T2 - Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors
AU - Chicago Consensus Working Group
AU - Izquierdo, Francisco J.
AU - Plana, Alejandro
AU - Schuitevoerder, Darryl
AU - Hayes-Jordan, Andrea
AU - Deneve, Jeremiah L.
AU - Al-Kasspooles, Mazin
AU - Bowne, Wilbur B.
AU - Brown, Charles Komen
AU - Kane, John M.
AU - Kelly, Kaitlyn J.
AU - Kennedy, Timothy J.
AU - Maduekwe, Ugwuji N.
AU - Mak, Grace Z.
AU - Melis, Marcovalerio
AU - Royal, Richard
AU - Abbott, Daniel E.
AU - Abdel-Misih, Sherif
AU - Amersi, Farin
AU - Arrington, Amanda K.
AU - Badgwell, Brian
AU - Barone, Robert M.
AU - Baumgartner, Joel M.
AU - Berri, Richard N.
AU - Bijelic, Lana
AU - Blazer, Dan G.
AU - Catenacci, Daniel V.
AU - Chan, Carlos H.F.
AU - Cho, Clifford S.
AU - Choudry, M. Haroon A.
AU - Clarke, Callisia N.
AU - Cusack, James C.
AU - Dachman, Abraham H.
AU - Dineen, Sean P.
AU - Eng, Oliver S.
AU - Fernandez, Leopoldo J.
AU - Fleshman, James
AU - Clark Gamblin, T.
AU - Gangi, Alexandra
AU - Georgakis, Georgios V.
AU - Gilbert, Erin W.
AU - Goodman, Martin D.
AU - Govindarajan, Anand
AU - Grotz, Travis E.
AU - Gushchin, Vadim
AU - Hanna, Nader
AU - Harmath, Carla
AU - Husain, Aliya N.
AU - Idrees, Kamran
AU - Ihemelandu, Chukwuemeka
AU - Merkow, Ryan P.
N1 - Funding Information:
Funded by the Irving Harris Foundation and the University of Chicago.
Funding Information:
James C. Cusack reports grants from Lumicell, Inc, outside the submitted work. Carla Harmath serves on the medical advisory council of Accumen. Hedy Kindler reports personal fees and nonfinancial support from Inventiva, AstraZeneca, Boehringer Ingelheim, Merck, and Paredox; personal fees from Aldeyra Therapeutics, Bayer, Bristol‐Myers Squibb, Erytech, Five Prime Therapeutics, Ipsen Pharmaceuticals, Kyowa, and MedImmune; and funds to support clinical trials at her institution from Aduro, AstraZeneca, Bayer, Bristol‐Myers Squibb, Deciphera, GlaxoSmithKline, Lilly, Merck, MedImmune, Polaris, Verastem, and Blueprint, all outside the submitted work. Aytekin Oto reports grants from Philips Healthcare, Guerbet, and Profound Healthcare and serves as a medical advisory board member for Profound Healthcare, all outside the submitted work. Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. Jesus Esquivel reports personal fees from Eight Medical. The other authors made no disclosures.
Publisher Copyright:
© 2020 by the American Cancer Society and Society of Surgical Oncology
PY - 2020/6/1
Y1 - 2020/6/1
N2 - The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of desmoplastic small round cell, breast, and gastrointestinal stromal tumors specifically related to peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.
AB - The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of desmoplastic small round cell, breast, and gastrointestinal stromal tumors specifically related to peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.
KW - breast neoplasms
KW - consensus
KW - desmoplastic small round cell tumor
KW - gastrointestinal stromal tumor
KW - neoplasm metastasis
KW - peritoneal neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85084537054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084537054&partnerID=8YFLogxK
U2 - 10.1002/cncr.32856
DO - 10.1002/cncr.32856
M3 - Article
C2 - 32282072
AN - SCOPUS:85084537054
SN - 0008-543X
VL - 126
SP - 2566
EP - 2570
JO - Cancer
JF - Cancer
IS - 11
ER -
